Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P21554 (
cannabinoid receptor
)
3,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Activation of postsynaptic group 1 metabotropic glutamate receptors (mGluRs) by the agonist
DHPG
causes a long-term depression (DHPG-LTD) of excitatory transmission in the CA1 region of the hippocampus, as well as causing the release of endocannabinoids from pyramidal cells. As cannabinoid agonists cause a presynaptic inhibition at these synapses and
DHPG
-LTD is thought to be expressed, at least in part, by a presynaptic mechanism, we examined the possibility that endocannabinoids mediated
DHPG
-LTD. We find that antagonists of cannabinoid receptors reduce the acute depression induced by
DHPG
, but have no effect on the lasting depression. Furthermore, both the acute and the lasting effects of
DHPG
were unaffected in the CB1 knockout mouse. These findings suggest that endocannabinoids, acting on a non-
CB1 cannabinoid receptor
, contribute to the acute depression but not to
DHPG
-LTD. Presumably some other retrograde signalling mechanism is responsible for
DHPG
-LTD.
...
PMID:Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus. 1292 27